Research Project · Health
ADDF Diagnostics Accelerator Funding for FTD Biomarker Development
Alzheimer's Drug Discovery Foundationwww.alzdiscovery.org (opens in a new tab)Catalog updated
No deadline listed
- Amount
- $5,000,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
The Association for Frontotemporal Degeneration (AFTD) partners with the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) to fund cutting-edge biomarker development for frontotemporal dementia (FTD). The initiative has provided nearly $5 million through matched contributions from AFTD and ADDF to advance diagnostic tools and related research. Funding is intended for researchers pursuing FTD biomarker projects; specific applicant eligibility and application requirements are not provided in the available information.
In FundFit
Full eligibility
Source announcement
Similar programs
These details are in FundFit.